+ All Categories
Home > Documents > AKI & CKD

AKI & CKD

Date post: 14-Jan-2016
Category:
Upload: chengzhi-khor
View: 31 times
Download: 0 times
Share this document with a friend
Description:
Short presentation on AKI and CKD
Popular Tags:
61
Changes in urine volume
Transcript
Page 1: AKI & CKD

Changes in urine volume

Page 2: AKI & CKD
Page 3: AKI & CKD
Page 4: AKI & CKD

Nephrotic syndromeEtiology: Primary: Minimal change disease, membranous nephropathy, focal segmental glomerulosclerosis

Secondary: Diabetic nephropathy, SLE, amyloidosis, infections (eg: HBV, HCV, HIV), malignancy (lymphoma, leukemia)

Pathophysiology: Increase permeability of the filtration barrier, loss of negative charge of the membrane

Symptoms: Hypoalbuminaemia, Proteinuria (>3.5g/day), Oedema, Hyperlipidemia, Hypercoagulability, Immunosuppression

Page 5: AKI & CKD

Nephritic syndromeEtiology: Primary: Post streptococcal glomerulonephritis, IgA nephropathy, Membranoproliferative glomerulonephritis, Rapidly progressive glomerulonephritis

Secondary: Goodpasture syndrome, SLE, Henoch-Schonlein purpura

Pathophysiology: Cellular proliferation in glomerulus (mesangial and endothelial), presence of inflammatory cells (neutrophils, macrophages)

Symptoms: Hematuria, Proteinuria, Hypertension, Oliguria, Uremia

Page 6: AKI & CKD

Management of glomerular diseaseInvestigation:Urine FEME- detect RBC, WBC, cast, bacteria

24 hour urine collection- determine total urine proteinSerology- determine underlying causeRenal biopsy- determine pattern of glomerular damage

Treatment: If secondary, treat underlying causeIf primary, use immunosuppressive therapyACEI for antiproteinuric effect (caution in renal impairment)

Page 7: AKI & CKD

Case Scenario

Mrs BE , 35 years old , presents with fever , arthralgia and rash for 4 days.She has been unwell for around 2 months. Her problems began with symptoms of dyspepsia , which started after taking some ibuprofen for her knee pain which she developed after a car accident in year 2010.

Page 8: AKI & CKD

Initially she had self-medicated with Gaviscon and ranitidine (obtained from her local pharmacy), but her indigestion became so severe that around 1 month ago she attended her GP.

Page 9: AKI & CKD

She was prescribed omeprazole which relieved her symptoms within a few days. About a week later she noticed a faint red rash on her arms. Since then, she has felt increasingly unwell with daily fevers, arthralgia of the small joints of the hand and intermittent loin pain.

Page 10: AKI & CKD

There is no history of upper or lower respiratory tract symptoms. Her only other regularmedication is the OCP, which she has been taking for 7 years.She has no past medical history or family history of renal or autoimmune disease.She does not smoke nor does she drink alcohol. Works as an accountant.

Page 11: AKI & CKD

PHYSICAL EXAMINATION

•Temperature : 37.4 degree Celsius

•Blood pressure : 145 / 90 mm Hg

•Erythematous , macular rash predominantly over the dorsum of the forearms as well as the legs

•Mild tenderness in both flanks

•Examination is otherwise unremarkable

Page 12: AKI & CKD

INVESTIGATIONS

● Full blood count – Hb 12.1 g/dL WBC 11.1 × 10^9/L (eosinophils 1.2, normal range : 0.04–0.44), Platelets 534 × 10^ 9 /L

● Urine dipstick : Protein +++ , blood ++ , leucocytes +● ESR - 48 mm/h, CRP - 36 mg/L, ● LFT -normal, Albumin 34 g/L

Page 13: AKI & CKD

Acute Kidney Injury

- Previously known as Acute renal failure

- Abrupt and often but not necessarily reversible loss of renal function, which develops over hours to days and is characterised by rise in serum creatinine and urea often together with oliguria or anuria

Page 14: AKI & CKD

3 Categories of Acute Kidney Injury

1. Pre-renal AKI

2. Renal AKI

3. Post-renal AKI

Page 15: AKI & CKD

1. Pre-renal AKI

Any cause of hypoperfusion: - hypoperfusion- hypovolemia- low oncotic pressure- congestive heart failure- constrictive pericarditis- renal artery stenosis

Page 16: AKI & CKD

Diagnostic Testing for Pre-renal AKI

1. BUN to creatinine ratio of >15:1 and often >20:1

2. Urinary sodium is low (<20)3. Fractional excretion of sodium <1 percent (a

low urine sodium)4. Urine osmolality >5005. Hyaline casts

Page 17: AKI & CKD

2. Renal AKI- Tubular injury: acute tubular necrosis, ATN

- Ischemia, contrast dye, myeloma, heme pigment (rhabdomyolysis)

- Interstitium: acute interstitial nephritis, AIN - Allergic and drug reactions - Infections (HIV and toxoplasmosis)

- Glomerular: glomerulonephritis

Page 18: AKI & CKD

Diagnostic Testing for Renal AKI

1. BUN to creatinine ratio closer to 10:12. Urinary sodium >403. Urine osmolality <350

Page 19: AKI & CKD

3. Post-renal AKI (obstructive uropathy)

Any cause of obstruction:- stone in the bladder or ureters- strictures- cancer of the bladder, prostate or cervix- neurogenic bladder (atonic or noncontractile,

such as from multiple sclerosis or diabetes)

Page 20: AKI & CKD

Diagnostic Testing for Post-renal AKI

1. Urinalysis: frequently normal

2. Elevated BUN-to-creatinine ratio of >15:1

3. Haematuria if stones, hemorrhage, malignancy, or prostatic hypertrophy

Page 21: AKI & CKD

Investigations

•Urine FEME

•Blood – BUN , creatinine , ABG , Calcium , phosphate

•X-rays (KUB)

•Ultrasound (KUB)

•Intravenous urography

•CT abdomen

•Renal biopsy

Page 22: AKI & CKD

Management ● Administer glucose and insulin to correct hyperkalaemia if

K+> 6.5 mmol/L● Consider administering sodium bicarbonate (100 mmol) to

correct acidosis if pH < 7.0 (> 100 nmol/L)● Discontinue potentially nephrotoxic drugs and reduce doses

of therapeutic drugs according to level of renal function● Match fluid intake to urine output plus an additional 500 mL● to cover insensible losses once patient is euvolaemic● Measure body weight on a regular basis as a guide to fluid● requirements

Page 23: AKI & CKD
Page 24: AKI & CKD

Non-renal causes of imbalanced serum urea to creatinine ratio

● Gastrointestinal bleeding● Dehydration● High protein diet (E.g TPN - Total parenteral

nutrition)● High muscle mass● Steroid use● State of metabolic distress (Sepsis)

Page 25: AKI & CKD

Chronic Kidney Disease

Page 26: AKI & CKD

Patient’s detailsInitials: IARAge: 65Gender: MaleR/N no: HTAN 5008

Page 27: AKI & CKD

Chief ComplaintBilateral leg swelling for 2 months

Page 28: AKI & CKD

History of Presenting IllnessB/L leg swelling (2 months)

- progressively worsen- no pain, erythema, weakness, numbness

B/L scrotal swelling (1 month)- erythematous- no pain, changes in sensation

Exertional dyspnea (1 month)- duration: less than 5 minutes- relieved upon rest- no cough, URTI symptoms, chest pain, palpitation, sweating, headache, nausea

Increased urinary frequency (5 days)- reduced urine volume- no changes in color or characteristic

Reduced bowel movement (5 days)No abdominal enlargement or pain, no UTI symptoms, no fever

Page 29: AKI & CKD

Past Medical History1) gouty arthritis (since 2007)

- affects both big toes- aggravated by peanuts- medications: allopurinol, colchicine

2) h/o urolithiasis (2007)3) renal failure (2007)4) h/o haemodialysis (2007-2012)

- Rt IJC for 8 weeks- Lt AV fistula 2007-2012

5) hypertension (since March 2015)- medication: amlodipine- noncompliant to medication and diet

Page 30: AKI & CKD

Family History- mother had CKD- married, has 8 children- son (35 years old) has kidney disease

Page 31: AKI & CKD

Social History- works as a rubber tapper- chronic smoker (40 pack years)

stopped 2 years ago- does not consume alcohol or take any drugs- water restriction 800cc/day

noncompliant- noncompliant to hypertensive diet

Page 32: AKI & CKD

Physical Examination- alert, conscious, responsive- not in any pain or respiratory distress- I/V cannula attached on left hand

- BP: 188/88mmHgPR: 82 bpm, regular rhythm, strong volumeRR: 17 bpmSpO2: 96%

Page 33: AKI & CKD

Chest:- no scars, visible pulsation- apex beat not deviated- S1 S2 heard- no additional heart sounds or

murmurs, no thrills, no heaves

- trachea not deviated- symmetrical chest expansion- bibasal dullness on percussion- increased vocal resonance- vesicular breath sound- bibasal crepitation

Abdomen:- no scars, visible pulsation or

peristalsis- abdomen distended, umbilicus

inverted- soft, non-tender- no hepatomegaly, no splenomegaly- negative fluid thrills and shifting

dullness

Legs:- B/L pedal edema

Page 34: AKI & CKD

InvestigationsFBC:Hb: 8.9/dLMCV: 92.6 fLMCH: 31.2 pgWBC: 4.3 x 10^9/Lplatelet: 132 x 10^9/L

Renal Profile:Na: 139 mmol/LK: 5.5 mmol/LUrea: 19.8 mmol/LCr: 662 μmol/L

ABG:pH: 7.38HCO3: 15.4 mmol/L

Page 35: AKI & CKD

Medications- T. CaCO3 1.5g TDs- IV lasix 40mg OD- T. allopurinol 150mg OD- T. iberet folate 1/1 OD- T. amlodipine 10mg OD

Page 36: AKI & CKD

Pathophysiology and progression of Chronic Kidney Disease

Page 37: AKI & CKD

Risk factor related to chronic kidney disease

Risk factor Definition Examples

Susceptibility factors Increase susceptibility to kidney damage Older age, family history of CKD, reduction in kidney mass, low birthweight, US racial or ethnic minority status, low income or education

Initiation factors Directly initiate kidney damage Diabetes, high blood pressure, autoimmune disease, systemic infections, urinary tract infections, urinary stones, lower urinary tract obstruction, drug toxicity

Progression factors Cause worsening kidney damage or faster decline in GFR

Higher level of proteinuria, higher blood pressure, poor glycemic control in diabetes, smoking

End-stage factors Increase morbidity and mortality in kidney failure

Lower dialysis dose, temporary vascular access, anemia, lower serum albumin level, late referral to nephrologists

Page 38: AKI & CKD
Page 39: AKI & CKD

❏ Possible causes of glomerular scarring and proteinuria:❏ A rise in intraglomerular capillary pressure❏ Increase in glomerular permeability❏ Adaptive glomerular hypertrophy due to reduced

arteriolar and increased glomerular blood flow when there is reduced nephron mass.

❏ Glomerular hyperfiltration, in response to nephron loss, was postulated as a common pathway for the progression of CKD.

Page 40: AKI & CKD

❏ Angiotensin II modulates intraglomerular capillary pressure and GFR, causing vasoconstriction of postglomerular arterioles, thereby increasing the glomerular hydraulic pressure and filtration fraction.

❏ Increased intraglomerular capillary pressure causes haemodynamic injury to the capillary wall, resulting in glomerular sclerosis.

❏ Angiotensin II also modulates cell growth by upregulating TGF-β, a potent fibrogenic cytokine, increasing collagen synthesis and causes epithelial cell transdifferentiation to myofibroblast which contributes to matrix formation.

❏ Proteinuria promotes secretion of pro-inflammatory mediators, which promote interstitial inflammatory cell infiltrate and augment fibrosis and progression of CKD.

Page 41: AKI & CKD

Complications of ckd

1. Anaemia-Erythropoietin deficiency-Bone marrow toxins retained-Bone marrow fibrosis 2o hyperparathyroidism-Haematinic deficiency-Increased RBC destruction during dialysis-Abnormal RBC membranes-Increased blood loss

Page 42: AKI & CKD

2. Renal osteodystrophy-Reduced excretion of phosphates-Release of FGF 23 and other phosphaturic agents by osteoblast-FGF 23 downregulates 1-alpha-hydroxylase and causes phosphaturia-Decreased 1-alpha-hydroxylase reduces activation of vitamin D-Reduced activation and hypocalcemia causes secretion of PTH-Vitamin D required for calcium gut absorption-PTH promotes bone resorption and increased proximal renal tubular reabsorption of calcium-Secondary hyperparathyroidism causes increased osteoclastic activity and bone marrow fibrosis.

Page 43: AKI & CKD

3. Pruritus

-due to retention of nitrogenous waste products of protein catabolism

Page 44: AKI & CKD

4.Hypertension

Systolic dysfunction due to :-Myocardial fibrosis-Abnormal myocyte function due to uraemia-Calcium overload and hyperparathyroidism-Carnitine and selenium deficiency-Coronary artery calcification

Page 45: AKI & CKD

Treatment of CKDThe medical care of patients with CKD should focus on the following:

● Delaying or halting the progression of CKD● Diagnosing and treating the pathologic manifestations of CKD● Timely planning for long-term renal replacement therapy

Page 46: AKI & CKD

Delaying or halting the progression of CKD

● Treatment of the underlying conditions● Blood pressure control : ACE Inhibitors or Angiotensin Receptor Blockers● Management of protein : Vitamin D supplementation● Avoiding nephrotoxic drugs including intravenous (IV) radiocontrast media,

nonsteroidal anti-inflammatory agents (NSAIDs), and aminoglycosides

Page 47: AKI & CKD

Treating the pathologic manifestations of CKD● Anemia: erythropoietin treatment (Hb level to 10-12 g/dL)● Mineral and bone disorder: phosphate binders (eg, calcium acetate,

sevelamer carbonate, lanthanum carbonate)● Metabolic acidosis: Bicarbonate supplementation● Cardiovascular risk: - statin or statin plus ezetimibe (not for adults with dialysis-dependent CKD)- low-dose of aspirin● Oedema: high doses of loop diuretics(furesomide) with restriction of fluid

and sodium intake.● Restless legs: clonazepam or gabapentin

Page 48: AKI & CKD

Renal replacement therapy● Haemodialysis● Haemofiltration● Peritoneal Dialysis● Renal Transplant

Page 49: AKI & CKD

Haemodialysis● blood flows on one side of a semipermeable membrane while dialysis fluid

flows in the opposite direction on the other side. ● Solute transfer occurs by diffusion.

Indications: - fluid overload with oliguria- hyperkalaemia- hypercalcaemia- metabolic acidosis- uremic symptoms- GFR <15- acute poisoning

Page 50: AKI & CKD

HaemofiltrationPatient's blood is passed through a set of tubing (a filtration circuit) via a machine to a semipermeable membrane(the filter) where waste products and water (collectively called ultrafiltrate) are removed by convection.

Page 51: AKI & CKD

Peritoneal DialysisSterile solution containing glucose (called dialysate) is run through a tube into the peritoneal cavity, the abdominal cavity around the intestine, where the peritoneal membrane acts as a partially permeable membrane.

● Continuous ambulatory peritoneal dialysis ( CAPD)

● Automated peritoneal dialysis- Continuous cyclic peritoneal dialysis (CCPD)- Intermittent peritoneal dialysis (IPD)- Night intermittent peritoneal dialysis (NIPD)- Tidal intermittent peritoneal dialysis (TIPD)

Page 52: AKI & CKD

Renal Transplant best long-term outcome for patients with end-stage renal disease.

Types of graft:- Cadaveric donor- Non-heart beating donor- Living related donor - Live unrelated donation

Immunosuppressants: cyclosporin, azathioprine, prednisolone , pre-op anti-interleukin 2 receptor antibodies (basiliximab)

Contraindications: cancer, active infections, uncontrolled ischaemic heart disease, acquired immunodeficiency disease with opportunistic infections, active viral hepatitis ,extensive peripheral vascular disease, mental incapacity.

Page 53: AKI & CKD

RRT ComparisonHemodialysis Peritoneal Dialysis Renal Transplant

Pros ● Cheaper ● More freedom, can be done at home

● Greater liberty from dietary restrictions

● Easily tolerable by patients with poor cardiac reserve

● No vascular access● Conserves residual kidney

function

● Restores kidney function completely (for 10-15 years)

Cons ● Frequent traveling to dialysis centre

● Needs to be on anticoagulants● (risk of thrombosis)● AV fistula for vascular access -

may collapse/risk of infection● Hypotension● Dietary restrictions

● Risk of peritonitis● Needs to be disciplined and

knowledgeable in handling dialysis

● Costly

● Long waiting list● Extremely costly● Risk of organ rejection● Need to be on

immunosuppressants● Need to undergo second

transplant after transplanted kidney fails

Page 54: AKI & CKD

Urinary Tract Infections (UTI)

Page 55: AKI & CKD

Urinary Tract Infections (UTI)Most commonly : Escherichia coli species (80-90% of cases) Other causes : Klebsiella, Enterococcus, Proteus mirabilis and Staphylococcus saprophyticus.Most of the causative organisms are naturally present in the GI tract, which acts as a natural reservoir for potential UTIsMajor defense against UTI : complete emptying of the bladder during urination. Other mechanisms : urine acidity, vesicoureteral valve, and various immunologic and mucosal barriers.Spread via: 95% Ascension5% Haematogenous

Page 56: AKI & CKD
Page 57: AKI & CKD
Page 58: AKI & CKD

Symptoms and signs of UTI● Frequency of micturition● Dysuria● Suprapubic pain & tenderness● Haematuria● Smelly urine● Loin pain & tenderness● Fever & systemic upset(chills, rigors, flank pain, colicky abdominal pain, nausea, vomiting)

Pyelonephritis

Cystitis

Page 59: AKI & CKD

Investigations & TreatmentIx:

Urinalysis (clean-catch, midstream specimen)

● Microscopic examination of urine : > 10 WBCs/μL

● Dipstick tests

Urine culture

● Culture criteria for symptomatic patients : Uncomplicated cystitis in women: > 10 3 /mL

Complicated UTI: > 10 5 /mLTx:Antibiotics: Amoxicillin/trimethoprim/cephalosporin (if resistance, co-amoxiclav(Augmentin)/

ciprofloxacin)

Page 60: AKI & CKD

Acute Kidney Injury VS Chronic Kidney Disease

Page 61: AKI & CKD

Acute Kidney Injury Chronic Kidney Failure

Progression* Rapid progressive loss of renal function

Gradual loss of renal function

Onset & Duration of symptoms* Acute, Hours to Days Gradual, >3 months

Symptoms Oliguria, Edema (Fluid overload), Arrhythmia (↑ K+) , metabolic acidosis (Unable to form HCO3-).

Oliguria/Anuria + Renal osteodystrophy*, Anemia*, Edema (fluid overload), mild metabolic acidosis, pruritus (cutaneous urea deposition

Anemia Possible due to pathological cause of AKI e.g Haemorrhage

Normochromic, normocytic Present due to ↓ erythropoetin production

Osteodystrophy Absent Present

Serum Calcium & Phosphate Normal Increased phosphate, decreased calcium(Increased calcium in secondary hyperparathyroidism

USG Enlarged kidneys Shrunken Kidneys/ Normal (PKD)


Recommended